AKT1 and non-small cell lung carcinoma: Nitroxoline enhanced NSCLC cell radiosensitivity by suppressing STAT3-AKT-mTOR survival signaling, promoting apoptosis, and amplifying radiation-induced DNA damage, indicating the potential of repurposing nitroxoline as a radiosensitizer to improve radiotherapy outcomes in patients with NSCLC.